These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7368457)

  • 1. Altered distribution of acid phosphatase in neoplastic prostatic cells.
    Fischer DR; Gevers W
    Urol Res; 1980; 8(1):15-22. PubMed ID: 7368457
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
    Mori K; Wakasugi C
    J Urol; 1985 May; 133(5):877-83. PubMed ID: 2580998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of acid phosphatase activity in human prostatic carcinoma cell cultures by serum.
    Kirk D; Narayan KS; Vener G; Kaighn ME
    Ann N Y Acad Sci; 1982; 390():62-72. PubMed ID: 7046590
    [No Abstract]   [Full Text] [Related]  

  • 4. The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
    Fischer DR; Gevers W; Klerk JN; Kühn S
    Int Urol Nephrol; 1979; 11(2):111-8. PubMed ID: 89105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of acid phosphatase isoenzyme in a human prostatic cancer cell line.
    Lin CT; Liu JW; Wu JY; Dang H; Li CY; Lam KW
    Lab Invest; 1986 Dec; 55(6):666-72. PubMed ID: 3784536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
    Mahan DE; Bruce AW; Manley PN; Franchi L
    J Urol; 1980 Oct; 124(4):488-91. PubMed ID: 6158585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of histochemical and electromicroscopical studies of total prostatectomy specimens.
    Kirchheim D
    Prog Clin Biol Res; 1976; 6():357-61. PubMed ID: 1023216
    [No Abstract]   [Full Text] [Related]  

  • 8. [An electron microscopic study of the human prostatic cancer: with special references to lysosomal system in prostatic cancer and to high dose estrogen effect upon prostatic cancer].
    Ishikawa F
    Nihon Hinyokika Gakkai Zasshi; 1971 Jun; 62(6):439-66. PubMed ID: 5104091
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and electrophoretic properties of acid phosphatase isozymes and their distribution in cell functions from neoplastic prostatic tissues.
    Fischer DR; Gevers W
    Urol Int; 1980; 35(3):216-25. PubMed ID: 6155728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
    Alsabti EA; Safo M
    Urol Int; 1979; 34(5):350-5. PubMed ID: 494437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple immunohistochemical method for the detection of prostatic acid phosphatase.
    Lee P; Lam KW; Li CY; Yam LT
    Arch Pathol Lab Med; 1981 Apr; 105(4):205-6. PubMed ID: 7011253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?
    Quinones GR; Rohner TJ; Drago JR; Demers LM
    J Urol; 1981 Mar; 125(3):361-4. PubMed ID: 6162969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of acid phosphatase in prostatic carcinoma].
    Bauer HW; Walther V; Schmiedt F
    Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
    Belville WD; Cox HD; Mahan DE; Stutzman RE; Bruce AW
    J Urol; 1979 Apr; 121(4):442-6. PubMed ID: 439214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
    Fosså SD; Sokolowski J; Theodorsen L
    Br J Urol; 1978 May; 50(3):185-9. PubMed ID: 753458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
    Warhol MJ; Longtine JA
    J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
    Murphy GP; Reynoso G; Kenny GM; Gaeta JF
    Cancer; 1969 Jun; 23(6):1309-14. PubMed ID: 4306102
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostatic acid phosphatase: its current clinical status.
    Heller JE
    J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochemistry and biochemistry of acid phosphatases. VI: Immunoelectron microscopic studies on human prostatic and leukocytic acid phosphatases.
    Aumüller G; Seitz J
    Prostate; 1985; 7(2):161-9. PubMed ID: 2413431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.